Futuremeds Ltd
Other professional, scientific and technical activities n.e.c. · Wirral
ActiveUnited KingdomIncorporated 2020Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Group accounts
Net assets
£7,065,683
Cash
£3,471,120
Turnover
£37,198,343
Profit / loss
£970,010
Current assets
£24,626,698
Creditors < 1 year
£14,729,474
Equity
£7,065,683
Average employees
461
Balance-sheet trend
GBP · consolidatedFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Group · AI-read | 2024-12-31Group · AI-read | 2022-12-3112 months | 2021-12-3112 months | 2020-12-319 months |
|---|---|---|---|---|---|
| Balance sheet | |||||
| Net assets | £7,065,683 | £5,868,863 | £554,815 | £1,936,881 | £1,222,104 |
| Equity | £7,065,683 | £5,868,863 | — | — | — |
| Share capital | £2,963,607 | £2,958,748 | — | — | — |
| Retained earnings | £3,541,657 | £2,571,647 | — | — | — |
| Assets | |||||
| Fixed assets | £15,224,395 | £12,223,405 | £725,405 | £365,670 | £2,300 |
| Intangible assets | — | — | £665 | — | — |
| Property, plant & equipment | £2,390,124 | £1,330,650 | £53,150 | £1,942 | — |
| Investments | £1,260 | £1,185 | — | — | — |
| Current assets | £24,626,698 | £13,456,843 | £3,708,557 | £3,788,858 | £1,494,878 |
| Cash at bank | £3,471,120 | £2,636,122 | £1,008,559 | £2,745,627 | £603,415 |
| Debtors | £21,155,578 | £10,820,721 | — | — | — |
| Liabilities | |||||
| Creditors | £32,785,410 | £19,811,385 | — | — | — |
| Creditors within one year | £14,729,474 | £11,503,525 | £1,768,352 | £298,742 | £2,922 |
| Creditors after one year | £18,055,936 | £8,307,860 | £2,110,795 | £1,918,905 | £272,152 |
| Net current assets | — | — | £1,940,205 | £3,490,116 | £1,491,956 |
| Assets less current liabilities | — | — | £2,665,610 | £3,855,786 | £1,494,256 |
| Profit & loss | |||||
| Turnover | £37,198,343 | £26,966,653 | — | — | — |
| Cost of sales | £19,886,750 | £15,523,172 | — | — | — |
| Gross profit | £17,311,593 | £11,443,481 | — | — | — |
| Administrative expenses | £13,341,517 | £9,289,913 | — | — | — |
| Other operating income | £25,268 | £1,193,578 | — | — | — |
| Operating profit | £3,995,344 | £3,347,146 | — | — | — |
| Interest receivable | £16,642 | £26,026 | — | — | — |
| Interest payable | £1,832,612 | £1,583,135 | — | — | — |
| Profit before tax | £2,179,374 | £1,790,037 | — | — | — |
| Tax | £1,209,364 | £7,045 | — | — | — |
| Profit / loss | £970,010 | £1,782,992 | — | — | — |
| Operating costs | |||||
| Depreciation | £429,076 | £398,472 | — | — | — |
| Amortisation | £266,595 | £274,970 | — | — | — |
| Cash flow | |||||
| Cash from operations | £1,452,074 | £1,955,708 | — | — | — |
| Capital expenditure | £1,449,406 | £578,899 | — | — | — |
| People & pay | |||||
| Average employees | 461 | 397 | 18 | 3 | 1 |
| Source evidence | View filing | View filing | View filing | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Clean (unmodified)
- Immediate parent
- FutureMeds Bidco Ltd
- Ultimate parent
- FutureMeds Topco Ltd
- Ultimate controlling party
- Phoenix Equity Partners, together with management
- Accounts
- Full accounts · IFRS
- Approved
- 2026-06-30, signed by P Maddison
Subsidiaries (1)
- Community Pharmacology Services Limited
Turnover by segment (10)
- UK: 9,585,434 (2025-12-31)
- Europe: 27,612,909 (2025-12-31)
- UK: 6,668,986 (2024-12-31)
- Europe: 20,297,667 (2024-12-31)
- Clinical trials: 33,127,638 (2025-12-31)
- Futuremeds Home: 3,612,970 (2025-12-31)
- Commercial visits: 457,735 (2025-12-31)
- Clinical trials: 23,702,398 (2024-12-31)
- Futuremeds Home: 2,766,704 (2024-12-31)
- Commercial visits: 497,551 (2024-12-31)
Borrowings (2)
- Loans and borrowings · (11,570,857)
- Loan notes · 390,205
Share classes (2)
- 397 D shares of GBP 12.24 each
- 38,796,424 Deferred shares of £0.01 per share
Events after the year end (1)
- There have been no significant events affecting the Group since the year end.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
4 outstanding chargesFixed · created 2025-11-04
—
OutstandingFixed · created 2025-11-04
—
OutstandingFloating · created 2025-11-04
—
OutstandingFixed · created 2025-11-03
—
OutstandingShow 1 satisfied / released
All Assets · created 2024-02-16 · satisfied 2025-10-31
—
Satisfied